期刊
TOXICOLOGIC PATHOLOGY
卷 44, 期 7, 页码 927-930出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/0192623316656416
关键词
testes; toxicity; safety assessment
In July 2015, the U.S. Food and Drug Administration (FDA) posted a new draft guidance entitled Testicular Toxicity: Evaluation during Drug Development Guidance for Industry, with a 90-day public comment period. As the nonclinical assessment of testicular toxicity often relies on the expert interpretation of pathology affecting the male reproductive tract, this draft guidance is considered directly relevant to the toxicologic pathology community. Therefore, a working group was formed through the Scientific and Regulatory Policy Committee of the Society of Toxicologic Pathologists (STPs) to provide a detailed review of the draft guidance. Specific comments on the guidance were submitted to the FDA by the STP. The draft guidance and all comments received are currently under review with the FDA. This commentary provides a summary of the components of the draft guidance and the comments submitted by the STP with acknowledgment of different perspectives reflected in comments from other respondents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据